About the Authors

Elisabet Jerlhag

elisabet.jerlhag@pharm.gu.se

Affiliation Section for Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

Anna Carin Janson

Affiliation NeuroSearch Sweden AB, Gothenburg, Sweden

Susanna Waters

Affiliation NeuroSearch Sweden AB, Gothenburg, Sweden

Jörgen A. Engel

Affiliation Section for Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden

Competing Interests

Susanna Waters and Anna Carin Jansson are employees of NeuroSearch Sweden AB, but have no competing interests in regards to the present manuscript. Jörgen A Engel and Elisabet Jerlhag are board members of Abunon AB, owning a patent regarding treating chemical substance addiction by administering a compound that blocks ghrelin action. However, this does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: EJ JAE. Performed the experiments: EJ ACJ. Analyzed the data: EJ ACJ. Contributed reagents/materials/analysis tools: EJ ACJ. Wrote the paper: EJ ACJ SW JAE.